FindTrial
Sign In

Clinical Utility of Thromboelastography to predict complications in Covid-19

Clinical Utility of Thromboelastography to predict complications in Covid-19 patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/09/036225
Enrollment
147
Registered
2021-09-03
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: nil: nil

Sponsors

Prithvishree Ravindra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with COVID-19, presenting to Emergency Department

Exclusion criteria

Exclusion criteria: Patients who have known bleeding disorders Patients who do not consent

Design outcomes

Primary

MeasureTime frame
A.To document the Thromboelastography (TEG) findings of COVID19 patients B.To explore the utility of TEG to predict coagulopathy of COVID19 patients C. To predict mortality and morbidity of patients using TEG in COVID-19 patients Timepoint: Baseline Discharge 1 month—

Secondary

MeasureTime frame
A. To document the Thromboelastography (TEG) findings of COVID19 patients B.To explore the utility of TEG to predict coagulopathy of COVID19 patients C. To predict mortality and morbidity of patients using TEG in COVID-19 patients Timepoint: Baseline Discharge 1 month—

Countries

India

Contacts

Public ContactPrithvishree Ravindra

Kasturba Medical College, Manipal

prithvishree@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026